General Information of the Protein
Protein ID
PT07548
Protein Name
3-hydroxy-3-methylglutaryl-coenzyme A reductase
Gene Name
HMGCR
Sequence
MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSSDIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTGLNEALPFFLLLIDLSRASALAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIGVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFARVLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTTEHSKVSLGLDEDVSKRIEPSVSLWQFYLSKMISMDIEQVVTLSLAFLLAVKYIFFEQAETESTLSLKNPITSPVVTPKKAPDNCCRREPLLVRRSEKLSSVEEEPGVSQDRKVEVIKPLVVETESASRATFVLGASGTSPPVAARTQELEIELPSEPRPNEECLQILESAEKGAKFLSDAEIIQLVNAKHIPAYKLETLMETHERGVSIRRQLLSTKLPEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDGKEYQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETPEGFAVIKDAFDSTSRFARLQKLHVTMAGRNLYIRFQSKTGDAMGMNMISKGTEKALLKLQEFFPEMQILAVSGNYCTDKKPAAINWIEGRGKTVVCEAVIPAKVVREVLKTTTEAMIDVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVRSHMVHNRSKINLQDLQGTCTKKSA
    Show/Hide
Organism
Cricetulus griseus, Chinese hamster, Cricetulus barabensis griseus
Protein Classification
Enzyme
>
Oxidoreductase
Function
Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of cholesterol and other isoprenoids, thus plays a critical role in cellular cholesterol homeostasis.
    Show/Hide
Uniprot ID
P00347
Ensembl ID
ENSG00000113161
Subcellular Location
Endoplasmic reticulum membrane
Peroxisome membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000522 , CHO-7
Compound ID Compound Name Compound Formula
CP0570525
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylpentan-1-one
   Show/Hide
C33H49N3O3
 2
1
EC50 = 130 nM
   TI
   LI
   LO
   TS
2
EC50 = 220 nM
   TI
   LI
   LO
   TS
CP0568279
(3R)-3-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylbutan-1-one
   Show/Hide
C32H47N3O3
 1
1
EC50 = 280 nM
   TI
   LI
   LO
   TS
CP0568378
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-7-ethyl-7-hydroxynonan-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol
   Show/Hide
C32H56O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0574700
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-ethyl-6-hydroxyoctan-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol
   Show/Hide
C31H54O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0576380
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-7-hydroxy-7-methyloctan-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol
   Show/Hide
C30H52O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0576850
(2S)-2-[(1S,2R,13S,14S,17R,18S)-7-acetyl-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylpropan-1-one
   Show/Hide
C31H45N3O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0578374
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-prop-2-enylnon-8-en-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol
   Show/Hide
C33H54O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0579934
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol
   Show/Hide
C29H50O3
 1
1
EC50 = 410 nM
   TI
   LI
   LO
   TS
CP0576849
(4R)-N-(1-acetylpiperidin-4-yl)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanamide
   Show/Hide
C36H54N4O3
 1
1
EC50 = 430 nM
   TI
   LI
   LO
   TS
CP0579788
(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-prop-2-enylnon-8-en-2-yl]-4,4,10,13-tetramethyl-1,2,3,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,7-diol;hydrochloride
   Show/Hide
C33H55ClO3
 1
1
EC50 = 430 nM
   TI
   LI
   LO
   TS
CP0579933
(4R)-1-morpholin-4-yl-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-7-(2-methylpropanoyl)-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentan-1-one
   Show/Hide
C35H53N3O3
 1
1
EC50 = 430 nM
   TI
   LI
   LO
   TS
CP0580241
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(oxan-4-yl)pentanamide
   Show/Hide
C34H51N3O3
 1
1
EC50 = 480 nM
   TI
   LI
   LO
   TS
CP0580193
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-butanoyl-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylpentan-1-one
   Show/Hide
C35H53N3O3
 1
1
EC50 = 520 nM
   TI
   LI
   LO
   TS
CP0577941
ethyl (1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-17-[(2R)-5-morpholin-4-yl-5-oxopentan-2-yl]-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-triene-5-carboxylate
   Show/Hide
C34H51N3O4
 1
1
EC50 = 530 nM
   TI
   LI
   LO
   TS
CP0568366
1-[(1S,2R,13S,14S,17R,18R)-17-[(2R)-5-ethyl-5-hydroxyheptan-2-yl]-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-7-yl]ethanone
   Show/Hide
C33H52N2O2
 1
1
EC50 = 630 nM
   TI
   LI
   LO
   TS
CP0576851
(4R)-1-morpholin-4-yl-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-7-propanoyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentan-1-one
   Show/Hide
C34H51N3O3
 1
1
EC50 = 650 nM
   TI
   LI
   LO
   TS
CP0576852
(4R)-4-[(1S,2R,12R,13S,14S,17R,18R)-12-hydroxy-2,9,9,18-tetramethyl-7-(2-methylpropanoyl)-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylpentan-1-one
   Show/Hide
C35H53N3O4
 1
1
EC50 = 730 nM
   TI
   LI
   LO
   TS
CP0573077
(4R)-1-morpholin-4-yl-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-7-(2-methylprop-2-enoyl)-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentan-1-one
   Show/Hide
C35H51N3O3
 1
1
EC50 = 760 nM
   TI
   LI
   LO
   TS
CP0568861
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-methylpentanamide
   Show/Hide
C30H45N3O2
 1
1
EC50 = 820 nM
   TI
   LI
   LO
   TS
CP0577333
(4R)-1-morpholin-4-yl-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-5-thia-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),6,10-trien-17-yl]pentan-1-one
   Show/Hide
C30H45N3O2S
 1
1
EC50 = 830 nM
   TI
   LI
   LO
   TS
CP0550510
(5R)-5-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylhexan-1-one
   Show/Hide
C34H51N3O3
 1
1
EC50 = 980 nM
   TI
   LI
   LO
   TS
CP0578373
(6R)-6-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylheptan-1-one
   Show/Hide
C35H53N3O3
 1
1
EC50 = 1090 nM
   TI
   LI
   LO
   TS
CP0580232
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-piperidin-1-ylpentan-1-one
   Show/Hide
C34H51N3O2
 1
1
EC50 = 1260 nM
   TI
   LI
   LO
   TS
CP0577940
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-ethylpentanamide
   Show/Hide
C31H47N3O2
 1
1
EC50 = 1630 nM
   TI
   LI
   LO
   TS
CP0579932
ethyl (1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-17-[(2R)-5-morpholin-4-yl-5-oxopentan-2-yl]-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-triene-5-carboxylate
   Show/Hide
C34H50N2O5
 1
1
EC50 = 1840 nM
   TI
   LI
   LO
   TS
CP0576848
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-propylpentanamide
   Show/Hide
C32H49N3O2
 1
1
EC50 = 2030 nM
   TI
   LI
   LO
   TS
CP0570171
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanoic acid
   Show/Hide
C29H42N2O3
 1
1
EC50 = 2660 nM
   TI
   LI
   LO
   TS
CP0577332
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(2-morpholin-4-ylethyl)pentanamide
   Show/Hide
C35H54N4O3
 1
1
EC50 = 2730 nM
   TI
   LI
   LO
   TS
CP0564307
(4R)-4-[(1S,2R,13S,14S,17R,18R)-2,6,9,9,18-pentamethyl-7-thia-5-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanoic acid
   Show/Hide
C28H41NO2S
 1
1
EC50 = 3370 nM
   TI
   LI
   LO
   TS
CP0260331
(4R)-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanoic acid
   Show/Hide
C27H40N2O2
 1
1
EC50 = 3990 nM
   TI
   LI
   LO
   TS
CP0550508
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(2-methylphenyl)pentanamide
   Show/Hide
C36H49N3O2
 1
1
EC50 = 4470 nM
   TI
   LI
   LO
   TS
CP0570524
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(5-nitro-1,3-thiazol-2-yl)pentanamide
   Show/Hide
C32H43N5O4S
 1
1
EC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0578414
(4R)-4-[(1S,2R,13S,14S,17R,18R)-6-amino-2,9,9,18-tetramethyl-7-thia-5-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanoic acid
   Show/Hide
C27H40N2O2S
 1
1
EC50 = 4940 nM
   TI
   LI
   LO
   TS
CP0149977
(4R)-4-[(1R,2S,5R,6R,9S,10S)-1,5,14,14-tetramethyl-16,19-diazapentacyclo[11.8.0.02,10.05,9.015,20]henicosa-12,15,17,19-tetraen-6-yl]pentanoic acid
   Show/Hide
C28H40N2O2
 1
1
EC50 = 5020 nM
   TI
   LI
   LO
   TS
CP0576379
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(4-methylphenyl)pentanamide
   Show/Hide
C36H49N3O2
 1
1
EC50 = 5410 nM
   TI
   LI
   LO
   TS
CP0577130
(4R)-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-6-oxa-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4,7,10-trien-17-yl]pentanoic acid
   Show/Hide
C26H38N2O3
 1
1
EC50 = 5810 nM
   TI
   LI
   LO
   TS
CP0547274
(4R)-4-[(1S,2R,12R,13S,14S,17R,18R)-7-acetyl-12-hydroxy-2,9,9,18-tetramethyl-5,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-1-morpholin-4-ylpentan-1-one
   Show/Hide
C33H49N3O4
 1
1
EC50 = 8160 nM
   TI
   LI
   LO
   TS
CP0568377
(4R)-4-[(1R,2S,5R,6R,9S,10S)-17-amino-1,5,14,14-tetramethyl-16,18-diazapentacyclo[11.8.0.02,10.05,9.015,20]henicosa-12,15,17,19-tetraen-6-yl]-1-morpholin-4-ylpentan-1-one
   Show/Hide
C32H48N4O2
 1
1
EC50 = 8250 nM
   TI
   LI
   LO
   TS
CP0077533
(4R)-4-[(1S,2R,13S,14S,17R,18R)-2,9,9,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentanoic acid
   Show/Hide
C33H44N2O2
 1
1
EC50 = 8800 nM
   TI
   LI
   LO
   TS
CP0568376
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(5-methyl-1,3-thiazol-2-yl)pentanamide
   Show/Hide
C33H46N4O2S
 1
1
EC50 = 12580 nM
   TI
   LI
   LO
   TS
CP0580192
(4R)-1-morpholin-4-yl-4-[(1S,2R,13S,14S,17R,18R)-2,6,9,9,18-pentamethyl-7-oxa-5-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]pentan-1-one
   Show/Hide
C32H48N2O3
 1
1
EC50 = 28080 nM
   TI
   LI
   LO
   TS
CP0578372
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(1,3-benzothiazol-2-yl)pentanamide
   Show/Hide
C36H46N4O2S
 1
1
EC50 = 31360 nM
   TI
   LI
   LO
   TS
CP0573076
(4R)-4-[(1S,2R,13S,14S,17R,18R)-7-acetyl-2,9,9,18-tetramethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,10-trien-17-yl]-N-(4-methyl-1,3-benzothiazol-2-yl)pentanamide
   Show/Hide
C37H48N4O2S
 1
1
EC50 = 43880 nM
   TI
   LI
   LO
   TS
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT02011 3-hydroxy-3-methylglutaryl-coenzyme A reductase Homo sapiens, Human